SAVA stock forecast
Our latest prediction for Cassava Sciences, Inc.'s stock price was made on the Dec. 31, 2019 when the stock price was at 5.20$.
In the short term (2weeks), SAVA's stock price should underperform the market by -0.63%. During that period the price should oscillate between -11.28% and +28.72%.
In the medium term (3months), SAVA's stock price should underperform the market by -8.90%. During that period the price should oscillate between -31.07% and +41.49%.Get email alerts
About Cassava Sciences, Inc.
Cassava Sciences, Inc. engages in the development of novel drugs. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.
At the moment the company generates 41M USD in revenues.
On its last earning announcement, the company reported a loss of -0.10$ per share.
The book value per share is 1.08$
Three months stock forecastDec. 31, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|